Exit interviews administered to patients participating in the COSTOP placebo controlled randomised trial in Uganda

INTRODUCTION: COSTOP was a randomised controlled trial designed to assess the risks and benefits to HIV-infected participants stabilised on anti-retroviral treatment of stopping cotrimoxazole (CTX). In order to assess the extent to which patients may have had access to and used CTX other than that s...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Contemp Clin Trials Commun
Main Authors: Nunn, Andrew, Anywaine, Zacchaeus, Seeley, Janet, Munderi, Paula, Levin, Jonathan, Kasirye, Ronnie, Kamali, Anatoli, Abaasa, Andrew, Grosskurth, Heiner
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2016
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4918030/
https://ncbi.nlm.nih.gov/pubmed/27536738
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.conctc.2016.05.008
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki